TY - JOUR

T1 - Sulfoethyl Chitosan: From Synthesis and Physicochemical Characterization to Functional Applications and Patent Perspectives

AU - Bedritskikh, Ksenia S.

AU - Saeidi, Arsalan

AU - Ivanova, Anna E.

AU - Pestov, Alexander V.

AU - Litvinova, Ekaterina A.

AU - Drannikov, Aleksandr A.

N1 - This research was supported by the Ministry of Education and Science of the Russian Federation throughout the “Priority-2030” program at Novosibirsk State Technical University (project No. SP-3 Zh-5/1).

PY - 2026/9/2

Y1 - 2026/9/2

N2 - Sulfoethyl chitosan (SEC) is an anionic chitosan derivative obtained through N‑, O‑, or mixed O, N‑substitution with sulfoethyl groups, which significantly enhances water solubility across a wide pH range, imparts strong polyelectrolyte character, and confers heparin‑mimicking biological properties. This review provides a comprehensive overview of SEC synthesis approaches, chemoselective routes thereof, and the influence of the degree of substitution (DS) and substitution pattern on solubility, swelling, thermal stability, and metal‑ion sorption selectivity. Characterization techniques including ¹H NMR, elemental analysis, FT‑IR, X-ray diffraction and molecular weight determination approaches are discussed with their specific challenges for polyelectrolyte derivatives, including sample purity and aggregation. The impact of sulfoethylation on biological properties including anticoagulant activity, hemocompatibility, cytotoxicity, antimicrobial effect, DNA protective activity was evaluated for sulfoethylated chitosan and its precursors, chitin and chitin‑glucan complex, revealing distinct structure-activity trends governed by the degree of acetylation and substitution pattern. Representative applications include selective solid‑phase extraction of copper from environmental waters, anticoagulant coatings, and macroporous cryogels for long‑term bacterial stabilization at ambient temperatures over 12 months. Despite its versatility, SEC remains under‑patented compared to other chitosan derivatives. Critical knowledge gaps persist, including the absence of systematic DS-bioactivity and regioselectivity-bioactivity relationships and long‑term stability studies, which raises doubts on the industrial demand of the biopolymer. Future perspectives emphasize standardized protocols for characterization and for biological activity assessment, pilot manufacturing with reduced toxic and environmental impact, and interdisciplinary efforts to develop advanced functional materials. With focused attention on these priorities, SEC has potential to transition from a laboratory derivative to a commercially viable biopolymer.

AB - Sulfoethyl chitosan (SEC) is an anionic chitosan derivative obtained through N‑, O‑, or mixed O, N‑substitution with sulfoethyl groups, which significantly enhances water solubility across a wide pH range, imparts strong polyelectrolyte character, and confers heparin‑mimicking biological properties. This review provides a comprehensive overview of SEC synthesis approaches, chemoselective routes thereof, and the influence of the degree of substitution (DS) and substitution pattern on solubility, swelling, thermal stability, and metal‑ion sorption selectivity. Characterization techniques including ¹H NMR, elemental analysis, FT‑IR, X-ray diffraction and molecular weight determination approaches are discussed with their specific challenges for polyelectrolyte derivatives, including sample purity and aggregation. The impact of sulfoethylation on biological properties including anticoagulant activity, hemocompatibility, cytotoxicity, antimicrobial effect, DNA protective activity was evaluated for sulfoethylated chitosan and its precursors, chitin and chitin‑glucan complex, revealing distinct structure-activity trends governed by the degree of acetylation and substitution pattern. Representative applications include selective solid‑phase extraction of copper from environmental waters, anticoagulant coatings, and macroporous cryogels for long‑term bacterial stabilization at ambient temperatures over 12 months. Despite its versatility, SEC remains under‑patented compared to other chitosan derivatives. Critical knowledge gaps persist, including the absence of systematic DS-bioactivity and regioselectivity-bioactivity relationships and long‑term stability studies, which raises doubts on the industrial demand of the biopolymer. Future perspectives emphasize standardized protocols for characterization and for biological activity assessment, pilot manufacturing with reduced toxic and environmental impact, and interdisciplinary efforts to develop advanced functional materials. With focused attention on these priorities, SEC has potential to transition from a laboratory derivative to a commercially viable biopolymer.

KW - sulfoethyl chitosan

KW - biopolymer

KW - polysaccharide

KW - sulfoethylation

KW - synthesis

KW - characterization

KW - chitosan derivatives

KW - patent landscape

UR - https://www.scopus.com/pages/publications/105052958648

UR - https://www.mendeley.com/catalogue/852edea8-c308-39df-b929-561975923852/

U2 - 10.31489/2959-0663/3-26-12

DO - 10.31489/2959-0663/3-26-12

M3 - Article

VL - 31

SP - 14

EP - 37

JO - Eurasian Journal of Chemistry

JF - Eurasian Journal of Chemistry

SN - 2959-0663

IS - 3

M1 - 2

ER -